Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06005818
Title Molecular Residual Disease (MRD) Guided Adjuvant ThErapy in Renal Cell Carcinoma (RCC) (MRD GATE RCC)
Acronym MRD GATE RCC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Alabama at Birmingham
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.